ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00152425
Recruitment Status : Completed
First Posted : September 9, 2005
Last Update Posted : September 9, 2013
Sponsor:
Information provided by:
UCB Pharma

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2005
  Actual Study Completion Date : May 2005
Publications of Results:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):